Ministry of Health and Family Welfare
India’s total recovered cases are now double the active
cases
Total recoveries cross 12.3 lakh
Recovery Rate jumps to 66.31%
Case Fatality Rate further reduces to 2.1%
Posted On: 04 AUG 2020 7:55PM by PIB Delhi
With 12,30,509 total recoveries,
India’s recovered cases are twice the active cases, as of today. 44,306
patients discharged in the last 24 hours. This has taken the recovery rate
among COVID-19 patients to 66.31%. Coordinated implementation of COVID-19
management strategy by the Union and State/UT governments and selfless
sacrifice of all frontline health workers has ensured that the recoveries are
continuously on the rise.
The active cases (5,86,298)
account for 31.59% of total positive cases and all are under medical
supervision.
Effective containment,
aggressive testing and standardized clinical management protocols based on a
holistic Standard of Care approach continues to result in a progressively
reducing Case Fatality Rate (CFR). India has registered the lowest CFR since
the first lockdown at 2.10% as compared to the global average.
The mortality analysis of the present data shows that 50% of deaths have happened in the age group of 60 years and above; 37% deaths belong to 45 to 60 years age group; while 11% deaths belong to 26-44 years age group. This clearly highlights the people above the age of 45 belong to the high-risk group and country’s containment strategy is focusing on this group. In the gender wise distribution, 68% of people who died were men and 32% were women.
India has taken timely and graded measures to ensure availability of ventilators since the start of COVID-19 pandemic which had resulted in a spike in demand all across the world. India decided to encourage domestic supply of ventilators under ‘Make In India’ as 75% of the market depended on import and import restrictions were increasing along with the severity of the pandemic.
To meet the projected
requirement of 60,000 ventilators in the country, the Committee of
Technical Experts under Director General of Health Services (DGHS) under the
Ministry of Health & Family Welfare prescribed the Minimum Essential
Specifications for the basic ventilators to be procured for COVID-19 purposes
after due and extensive deliberation. The Empowered Group (EG) -3 was
constituted for addressing the issue of essential medical supplies. After
careful physical demonstration and clinical validation of the domestic
ventilator model, orders were placed.
Major orders were placed upon
two Public Sector Enterprises (PSEs) - Bharat Electronics Limited (BEL) and
Andhra Med-Tech Zone (AMTZ). In addition, the automobile industry also stepped
up along with Defence research and Development Organisation (DRDO). As of now,
the ‘Make in India’ ventilators have a market share more than 96% by volume and
more than 90% by value. As on date, they have been installed at more than 700
hospitals. In less than two months, more than 18000 ventilators have been
supplied to States/ UTs/ Central Govt. Hospitals/ DRDO facility.
For all authentic & updated
information on COVID-19 related technical issues, guidelines & advisories
please regularly visit: https://www.mohfw.gov.in/ and @MoHFW_INDIA.
Technical queries related to
COVID-19 may be sent to technicalquery.covid19@gov.in and other queries on
ncov2019@gov.in and @CovidIndiaSeva .
In case of any queries on
COVID-19, please call at the Ministry of Health & Family Welfare helpline
no.: +91-11-23978046 or 1075 (Toll-free). List of helpline numbers of
States/UTs on COVID-19 is also available at
https://www.mohfw.gov.in/pdf/coronvavirushelplinenumber.pdf.
****
MV/SG
HFW/COVID Updates/4thAugust2020/1
(Release ID: 1643359) Visitor Counter : 172
Ministry of Health and Family Welfare
India tests more than 6.6 lakh samples in last 24 hours
28 States/UTs conducting more than 140 tests/day/million
28 States/UTs with positivity rate less than 10%
Posted On: 04 AUG 2020 7:53PM by PIB Delhi
A record 6,61,892 samples were
tested for COVID-19 in the last 24 hours. This takes the cumulative testing to
2,08,64,750 samples and the Tests per Million (TPM) to 15,119.
The combined and focused efforts
of Union and State/UT Governments have resulted in ramped up testing across the
country aimed at early detection and isolation of COVID-19 positive cases. The evolving ICMR’s testing strategy has widened the
testing net in India.
WHO in its Guidance Note on
“Public Health Criteria to Adjust Public Health and Social Measures in the
Context of COVID-19” has advised comprehensive surveillance for suspected
cases. WHO advises that a country needs 140 tests per day per million population.
While India conducts 479
tests/day/million on an average, there are 28 States/UTs in India which are
conducting more than 140 tests/day/million, prescribed by WHO.
The focused strategy based on
the “Test, Track and Treat” approach focuses on reducing the Positivity Rate of
COVID-19 tests. India’s average positivity rate stands at 8.89%, as on date.
There are 28 States/UTs which have positivity less than 10% which indicates
that the testing strategy is on the right track. The effort of Centre and
State/UT governments is to further improve the Positivity Rate to 5%.
With the aim to conduct 10 lakh
tests daily, the testing capacity is being continuously ramped up. The testing
lab network in the country currently stands at a total of 1356 labs in the
country; 917 labs in the government sector and 439 private labs. These include:
• Real-Time RT PCR based testing labs: 691
(Govt: 420 + Private: 271)
• TrueNat based testing labs: 558
(Govt: 465 + Private: 93)
• CBNAAT based testing labs: 107
(Govt: 32 + Private: 75)
For all authentic & updated
information on COVID-19 related technical issues, guidelines & advisories
please regularly visit: https://www.mohfw.gov.in/ and @MoHFW_INDIA.
Technical queries related to
COVID-19 may be sent to technicalquery.covid19@gov.in and other queries on ncov2019@gov.in
and @CovidIndiaSeva .
In case of any queries on
COVID-19, please call at the Ministry of Health & Family Welfare helpline
no.: +91-11-23978046 or 1075 (Toll-free). List of helpline numbers of
States/UTs on COVID-19 is also available at https://www.mohfw.gov.in/pdf/coronvavirushelplinenumber.pdf .
****
MV/SG
HFW/COVID Testing/4thAugust2020/2
(Release ID: 1643357) Visitor Counter : 108
Ministry of Health and Family Welfare
Case Fatality Rate in the country is the lowest since
announcement of first lockdown: Health Ministry
Health Ministry narrates the saga of India becoming Aatma Nirbhar in COVID-19
ventilators
States should analyse testing data and mount locally specific data-driven
response at state and district levels: DG, ICMR
COVID-19 Vaccine: Prioritization and fair distribution, logistics of roll-out
in cold chain, stock-piling and training of people administering vaccine
crucial, says DG, ICMR
Posted On: 04 AUG 2020 6:59PM by PIB Mumbai
New Delhi / Mumbai, July
30, 2020
In India, more than 2 crore
COVID-19 tests have been conducted and more than 6.6 lakh tests have been done
in the last 24 hours itself. The number of recovered cases is now double of the
active cases. Further, Case Fatality Rate is now the lowest (2.10%) since the
first lockdown started on 25th March, 2020. This has been stated by the
Secretary, Ministry of Health and Family Welfare, Shri Rajesh Bhushan, in
course of a press briefing on the actions taken, preparedness and updates on
COVID-19 held at National Media Centre in New Delhi today.
The Health Secretary further
informed, 24 States and UTs have fared better on Monday (August 3) than the
national average of 15,119 tests per million. Goa leads with 84,927 tests per
million, followed by Delhi having conducted 57,855 tests per million population.
This indicates that many states and UTs have increased their testing capacities
- both RT-PCR and Rapid Antigen, stated Shri Bhushan. Further, 28 States and
UTs are performing more tests than World Health Organisation's guideline of 140
tests per day per million population. The country, on an average, is conducting
479 tests per day per million population. 28 States/UTs are showing a
positivity rate of less than 10%. In this connection, Shri Bhushan stated that
the Health Ministry analyses positivity on the basis of three parameters: 1)
measure of positivity in total numbers, 2) measure on the basis of total
testing in the country and in individual states and UTs, and 3) measure on the
basis of 7 days' rolling average. The cumulative positivity of India presently
stands at 8.89%. In the last week, the country's positivity rate was 11%, which
means that there are still certain states which needs focus as the positivity
is rising in those states, said the Health Secretary.
As on date, there are 5,86,298
active cases as against 12,30,509 recovered cases which is almost double the
number of active cases. On the other hand, the Case Fatality Rate has seen a
progressive decline from 3.36% in the second week of June and then 2.69% in the
second week of July to its lowest at 2.10% as on date. "This decline is
continuing which is a good sign", remarked Shri Bhushan. Again, the
Mortality analysis on the basis of age and gender show that: 1) 68% deaths have
been among male patients, 32% among female patients 2) 50% deaths have occurred
to people aged above 60 years, while 37% of deaths occurred to people in the
age group of 45- 60 years. Stating this, the Health Secretary reiterated the
need to take special care of senior citizens and their physical distancing. He also
noted that data shows 45-60 years’ age group is also vulnerable and called for
them to remain safe and follow the COVID
Appropriate Behaviours, especially if they have co-morbidities.
The Health Secretary also threw
light on the saga of how Indian domestic industry and innovators combined with
the Union Government to develop basic ICU-Ventilators. Starting from a scenario
where India's domestic manufacturing of ventilators was insignificant, now the
Union Government has accorded permission for export of ventilators. Prior to
COVID-19, 755 of ventilators in India were imported. Since March 2020, the
demand for ventilators spiked all over the world and many ventilator producing
countries imposed an export-restriction. At that time, even the limited
number of domestic manufacturers were dependent on imported components. At that
time, there was a projected requirement of 60,000 ventilators in the country,
although the situation was dynamic and evolving. "However, now we find
ourselves in a comfortable situation as far as patients requiring
ventilator-support are concerned", stated Shri Bhushan. Further, there was
no domestic standards for ventilators in India at that time, nor were these a
regulated medical device having BIS certification or under CDSCO regulations.
At that time, the Committee of Technical Experts under DGHS convened several
meetings with subject experts and came up with prescribed minimum essential
specifications for the basic ventilators to be procured for Covid-19 purposes.
Then, orders were placed based on the recommendations of the Technical
Committee of domain experts under DGHS. This was the beginning of the 'Make In
India' Ventilators for ICU. Two PSUs - Bharat Electronics Limited and Andhra
Med-Tech Zone played an important role by supplying 30,000 and 13,500 domestic
ventilators respectively. Maruti Suzuki, from the automobile industry supported
by providing its infrastructure to be used by the domestic manufacturer AgVA to
produce 10,000 ventilators. DRDO played a vital role in local designing and
manufacturing of components. Starting with the roll-out of the First
'Make in India' BEL make Ventilator on 30 May, 18,000 such ventilators are
being provided and installed in 700 hospitals. Health Ministry is tracking real
time status of dispatch, delivery and installation of ventilators through a
dashboard. Each of these ventilators are Geo tagged to track their location.
Further, the Health Ministry has created 36 WhatsApp Groups for each state and
UT with officials from Health Ministry, HLL, State representatives, doctors
from hospitals and suppliers in group, where issues related to ventilators are
raised and resolved by the concerned party.
Director-General, ICMR, Dr.
Balram Bhargava stated, a policy of intelligent and calibrated testing is being
followed, depending on which areas need more testing and setting up of labs are
identified. "We have also tried to set-up high throughput laboratories in
SEZs such that our economy also progresses and testing can happen more where
there are large international airports. The states have also been cooperating
immensely in testing and we are requesting them to reach up to 10 lakh tests
per day." He further said, it is important for states to analyse the data
and mount locally specific data driven response at the state-level and
district-level, what is called as 'Knowing The Epidemic'. Enough data is now
available for every state, district and testing laboratory and it will go a
long way in tackling the epidemic, he added.
Speaking about vaccines, the DG,
ICMR briefed, the pandemic is progressing rapidly and to develop a vaccine, it
needs time, not only in respect of science, but also social, cultural and
regulatory aspects. Presently there are three vaccines in different phases pf
clinical trials -
1) Bharat Biotech's inactivated
virus vaccine which has completed its Phase I safety and early efficacy studies
in 11 sites. Phase II studies have been commenced for it.
2) Zydus Cadila's DNA vaccine
has also completed Phase I studies in 11 sites and has started its Phase II
trials.
3) Recombinant Oxford vaccine to
be manufactured by Serum Institute of India, Pune has been given approval
yesterday for Phase I and II clinical trials to be started soon at 17 sites.
DG, ICMR also said, once a safe
and effective vaccine comes, we need to focus on prioritization and fair
distribution, logistics of roll-out in cold chain, stock-piling and training of
people. However, till vaccines become available and even after, sustainable
behavioural changes like physical distancing, wearing of mask etc. should be
maintained.
In reply to a media query, the
Health Secretary stated, Health Ministry has issued guidelines clarifying that
deaths of COVID19 patients with co-morbidities are to be treated as COVID-19
deaths, not death due to co-morbidities, to bring in a standardized way of
death reporting in the country. States including Maharashtra, which have
reported maximum number of COVID-19 cases and deaths, have a high rate of death
registration. The proportion of medically certified deaths among total
deaths too is high in these states. Hence, it is unjustified to say that deaths
are under-reported, he said.
In reply to a query on the
virus’ mutation, DG-ICMR stated, no major mutation has occurred in the strain
of SARS-COV2 virus. A mutation which results in total change of the virus takes
10 -15 years, he added.
@PIBMumbai tweets on today’s press
conference can be found in this link
*****
DJM/SC
*
Follow us on social media: @PIBMumbai /PIBMumbai /pibmumbai pibmumbai@gmail.com
(Release ID: 1643344) Visitor Counter : 84
No comments:
Post a Comment